The GIFT Nifty futures traded higher, up by 17.95 points or 0.08% at 22,465, indicating the domestic indices to open on a positive note on Wednesday. 

Domestic benchmark indices NSE Nifty 50 and S&P BSE Sensex ended higher due to heavy buying in index heavy-weights such as TCS, HDFC Bank, and Reliance Industries amid mixed cues from Asian markets.

Nifty ended flat at 22,335.70, gaining marginally by 3.05 points or 0.01%, and the BSE Sensex gained 165.32 points or 0.22% and settled at 73,667.96. 

Here are some stocks that are likely to remain in focus on 13 March.

Aurobindo Pharma: The company’s subsidiary, Eugia Pharma, has restarted the distribution of aseptic products and plans to commence commercial production from septic lines in a phased manner starting next week.

ITC: British American Tobacco has revealed its plans to sell a 3.5% stake in the company via a block deal at an average price of Rs 384-400.25 per share.

Vedanta: The Securities Exchange Board of India (SEBI) has instructed the company to pay Rs 77.62 crore to Scottish explorer Cairn for delayed dividend payments. Furthermore, the entire Board of Directors has been prohibited from accessing the capital market for similar reasons. 

Shalby: The Multi-speciality hospital chain has acquired a 100% stake in Healers Hospital Private Ltd for a total acquisition cost of Rs 104 crore. 

Shree Cement: The company has entered into an asset purchase agreement with Starcrete LLP to acquire five ready-mix concrete plants for a total consideration of Rs 33.5 crore. 

Muthoot Capital: The Kerala-based company has partnered with Greaves Finance Ltd. to enhance the accessibility of financing solutions for electric two-wheelers across the country.

Glenmark Life Sciences: Ahmedabad-based company Nirma has successfully acquired a 75% stake in the company.